Navigation Links
FPR Specialty Pharmacy Hires Slomski To Lead Sales And Marketing; Moves To Next Phase In Cleveland Clinic Trials
Date:1/8/2014

VICTOR, N.Y., Jan. 8, 2014 /PRNewswire/ -- FPR Specialty Pharmacy, developer of Focused Pain Relief—custom transdermal creams for pain and inflammation—today announced the appointment of Douglas B. Slomski to the position of Vice President of Sales and Marketing.  Effective immediately, Slomski will be responsible for expanding the company's presence in existing markets, as well as opening new markets and launching products. The company also announced today that the Cleveland Clinic study for the treatment of knee pain using Diclofenac Cream 8% or 1% has moved to the next phase, with participant enrollment to begin in the first quarter of 2014.

Slomski brings to FPR Specialty Pharmacy a 25-year background in marketing life-science products and extensive expertise in medical sales management. He most recently served on the management team at ECA Medical Instruments, where he helped with the global unveiling of a line of surgical kitting products and oversaw a five-year branding and implementation program.  Known for his solutions-based approach, Slomski is a global expert at growing revenue and market share through end-to-end product management and targeted sales strategies. He is also credited with over 12 patents in medical devices, packaging and sterilization processing equipment.

"FPR Specialty Pharmacy has exciting and aggressive plans to move the company forward in 2014. Doug Slomski is a top talent in the industry and his knowledge will further strengthen our management team and our position to achieve our goals," said Billy Rue, CEO of FPR Specialty Pharmacy.

As part of its expansion efforts, FPR Specialty Pharmacy is engaging in the Cleveland Clinic study to measure the effectiveness of Diclofenac creams in treating knee pain.  This research will provide valuable insights for treating pain and inflammation in the knee.  "This is a hallmark study for our industry and we greatly value partnering with the Cleveland Clinic on this project," said Rue. 

ABOUT FPR SPECIALTY PHARMACY
FPR Specialty Pharmacy is an advanced traditional compounding pharmacy specializing in solutions for relief of pain and inflammation.  The company's leading product, Focused Pain Relief, is a custom compounded, prescription-based transdermal cream. FPR Specialty Pharmacy is located in Victor, New York.  Learn more at: www.focusedpainrelief.com or follow FPR Specialty Pharmacy on LinkedIn.


'/>"/>
SOURCE FPR Specialty Pharmacy
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Numotion Acquires Specialty Wheelchairs, LLC
2. Endo to Acquire Specialty Pharmaceutical Company NuPathe
3. New Physicians Survey: Most Drugstores Lack the Expertise and Capability to Provide Specialty Medications
4. Giant Eagle Expands Specialty Pharmacy with Acquisition, Bringing Treatment Expertise to Customers with Hepatitis C and Organ Transplant Conditions
5. Tampa Pharmacist Receives Specialty Pharmacy Certification Credential from SPCB
6. Centene Specialty Pharma Subsidiary Receives Full URAC Accreditation
7. CVS Caremark to Purchase Coram Infusion Business from Apria Healthcare, Expanding Specialty Pharmacy Offering
8. Student Residency Program Planned by the National Association of Specialty Pharmacy (NASP)
9. Global Markets For Specialty Surgical Wound Care Products In 2013: Surgical Sealants, Glues, Absorbable Hemostats, And Adhesion Prevention Products
10. Covance Central Laboratories and NeoGenomics Enter into Exclusive Alliance to Provide Comprehensive Anatomic Pathology, Histology and Specialty Laboratory Testing Services for Clinical Trials
11. Pan Foundation Convenes Dialogue Series On Issues Surrounding Access To Specialty Medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... TARE (Transarterial Radio-embolization) Using ... and Overall Decreased Use of Hospital Resource ... specialist healthcare company, has today announced the publication ... of ISPOR (International Society for Pharmacoeconomics and Outcomes ... using yttrium-90 glass microspheres is associated with cost ...
(Date:5/25/2016)... , May 25, 2016 According ... by Type (3D, 2D, 4D), by Therapeutic Area (Oncology, ... End User (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast ... global Medical Animation Market for the forecast period of ... USD 301.3 Million by 2021 from USD 117.3 Million ...
(Date:5/25/2016)... , May 25, 2016  According to Kalorama Information, ... billion in 2015.  Though these are challenging times ... opportunity for success for companies that remain optimistic ... of new growth prospects medical device companies spend ... and development (R&D) than do companies in other ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... ... Southland Log Homes , designer and manufacturer of America’s Favorite Log ... be found on its website at SouthlandLogHomes.com. , The designs of the wood ... craftsmanship of timber post and beam construction. The result is a barn that ...
(Date:5/27/2016)... York, NY (PRWEB) , ... May 27, 2016 , ... ... factors of a stroke, which we as a society can control and change. , ... stroke occurs nearly every 40 seconds within the United States. Plus, with an estimated ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees ... which come courtesy of leaders in the nursing and health care industry. It also ... and associations—namely Abilene Christian University. , As the nursing industry is coming out ...
(Date:5/26/2016)... Hampshire (PRWEB) , ... May 26, 2016 , ... ... care products, has been honored with a 2016 When Work Works Award for its ... award, part of the national When Work Works project administered by the Families and ...
(Date:5/26/2016)... ... ... On Memorial Day, Hope For Heroes and USA Medical Card ... the country. The nonprofit Hope For Heroes partnered with the leading provider of ... disabled military veterans, as well as police, firemen, and EMS professionals across the country, ...
Breaking Medicine News(10 mins):